(Q47879693)

6 February 2018

title

Drug resistance in ovarian cancer - the role of p53. (English)

1 reference

6 February 2018

1 reference

R Petty

1

1 reference

6 February 2018

A Evans

2

1 reference

6 February 2018

I Duncan

3

1 reference

6 February 2018

C Kurbacher

4

1 reference

6 February 2018

I Cree

5

1 reference

6 February 2018

publication date

1 January 1998

1 reference

6 February 2018

Pathology Oncology Research

published in

1 reference

6 February 2018

volume

4

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

97-102

1 reference

6 February 2018

bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02904701

Expression and prognostic significance of Bcl-2 in ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02904701

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02904701

Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02904701

p53 protein overexpression and chemosensitivity in breast cancer.

21 January 2018

1 reference

12 December 2020

p53 status and the efficacy of cancer therapy in vivo

1 reference

12 December 2020

p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity

1 reference

12 December 2020

Expression of p53 protein has no independent prognostic value in breast cancer

1 reference

12 December 2020

Thymocyte apoptosis induced by p53-dependent and independent pathways.

1 reference

12 December 2020

Tumour suppressor genes in disease and therapy

1 reference

12 December 2020

Individualizing chemotherapy for solid tumors--is there any alternative?

1 reference

12 December 2020

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

12 December 2020

Cancer. p53, guardian of the genome

1 reference

12 December 2020

The p53 tumour suppressor gene and tumour prognosis: is there a relationship?

1 reference

12 December 2020

The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.

1 reference

12 December 2020

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

12 December 2020

Cell cycle control and cancer

1 reference

12 December 2020

Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines

1 reference

12 December 2020

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

1 reference

12 December 2020

Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis

1 reference

12 December 2020

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression

1 reference

12 December 2020

Quantification of p53 in epithelial ovarian cancer

1 reference

12 December 2020

Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity.

1 reference

12 December 2020

p53 accumulation in ovarian carcinomas and its prognostic implications

1 reference

12 December 2020

Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

1 reference

12 December 2020

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

1 reference

12 December 2020

Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.

1 reference

12 December 2020

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

12 December 2020

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

12 December 2020

Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.

1 reference

12 December 2020

Role of p53 in drug resistance in ovarian cancer

1 reference

12 December 2020

The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patients

1 reference

12 December 2020

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

1 reference

12 December 2020

p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer

1 reference

12 December 2020

Chemotherapy-induced apoptosis in epithelial ovarian cancers

1 reference

12 December 2020

Bcl-2 protein expression and long-term survival in breast cancer

1 reference

12 December 2020

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

12 December 2020

Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer

1 reference

12 December 2020

Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02904701

1 reference

6 February 2018

1 reference

6 February 2018